Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG

Izumi Nakagawa, Masaaki Murakami, Kenichi Ijima, Shunsuke Chikuma, Izumu Saito, Yumi Kanegae, Hiroshi Ishikura, Takashi Yoshiki, Hiroshi Okamoto, Akira Kitabatake, Toshimitsu Uede

Research output: Contribution to journalShort surveypeer-review

57 Citations (Scopus)


Adenovirus vectors can transfer recombinant genes efficiently into a wide variety of cells in vivo, but have serious limitations: gene expression is transient and secondary gene transfer is inefficient or impossible because of cellular and humoral immune responses against adenovirus-transduced cells. To solve these limitations, we have constructed an adenovirus vector, Adex1CACTLA4IgG, that expresses CTLA4IgG molecules. After in vivo administration of Adex1CACTLA4IgG (9.0 x 109 PFU), the peak level of serum CTLA4IgG was 29.8 mg/ml on day 4. The serum CTLA4IgG concentration gradually fell but was still 5.7 mg/ml on day 90, However, the serum concentration of CTLA4IgG was elevated after a second administration of Adex1CACTLA4IgG. The production of antibody against adenovirus was completely prevented after treatment with Adex1CACTLA4IgG. In addition, coadministration of Adex1CALacZ with Adex1CACTLA4IgC induced persistent hepatic expression of β-Gal molecules, while administration of Adex1CALacZ alone induced transient expression of β-Gal molecules. More importantly, on day 160 a secondary challenge with Adex1CALacZ was possible in mice treated with Adex1CALacZ plus Adex1CACTLA4IgG. Thus, we have demonstrated that (1) gene expression of a recombinant adenovirus, Adex1CACTLA4IgG, is persistent in liver and secondary administration of this adenovirus is possible, (2) coadministration of Adex1CACTLA4IgG virus with another adenovirus, AdexCALacZ, prolongs AdexCALacZ-mediated gene expression, and (3) Adex1CACTLA4IgG is useful for secondary challenge with Adex1CALacZ.

Original languageEnglish
Pages (from-to)1739-1745
Number of pages7
JournalHuman Gene Therapy
Issue number12
Publication statusPublished - 1998 Aug 10
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics


Dive into the research topics of 'Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG'. Together they form a unique fingerprint.

Cite this